Wall Street Prep – Biotech Sum of the Parts Valuation

About Course:

What You Will Learn

• Market size and model potential revenue for a therapeutic asset in clinical development
• Road-map the path to commercialization for a biotech through the FDA approval process
• Apply the appropriate “probability of success”” to a clinical-stage pre-revenue biotech company
• Apply key assumptions and tie together a long-range forecast of multiple products with a DCF analysis

Biotech Sum of the Parts Valuation

• Biotech SOTP welcome
• Biotech SOTP introduction
• Course Downloads
• Overview of a sum of the parts valuation
• Major building blocks for a biotech SOTP
• Model assumptions dashboard
• Biotech company lifecycle
• Identify peak revenue opportunity
• Therapeutic areas overview
• Product launch timing and uptake curve
• Patent life and loss of exclusivity
• Road to commercialization
• FDA clinical trials
• Building a commercial infrastructure
• Completing the SOTP
• Probability of success
• Build out one part of the SOTP (Product #1)
• Finalizing the valuation model
• Valuation sensitivities
• Example: Blueprint Medicines Corp
• Biotech SOTP Course Review